JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC
Clinical trial NCT06969027 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06969027
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-19
- Primary completion
- 2027-12-31
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.